Spyre Therapeutics, Inc.

SEC 4 · Filed

0001636282-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jan 9, 2026

Grant, award or other acquisition by Sloan Sheldon

Security
Stock Option (Right to Buy)
Code
A
Shares
140,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-01-09",
  "direction": "A",
  "exercise_price": "30.61",
  "expiration": "2036-01-09",
  "footnotes": {
    "F1": "This option represents a right to purchase 140,000 shares of the Issuer\u0027s common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person\u0027s continued employment with the Issuer at each vesting date."
  },
  "owners": [
    {
      "cik": "0002038798",
      "name": "Sloan Sheldon",
      "roles": [
        "officer"
      ],
      "title": "Chief Medical Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "140000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (Right to Buy)",
  "shares": "140000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "140000"
}